Rockwell Medical Inc RMTI posted a wider-than expected fourth-quarter loss on sales that beat Wall Street views by a slim margin.
The Wixom, Michigan-based maker of dialysis kits wasn't trading in the extended session, but closed Thursday at $11.13, up nearly 4 percent.
Rockwell's net loss narrowed to $6.38 million, or $0.14 a share, from $8.33 million, or $0.21 a share last year.
Sales grew to $14.4 million from $13.9 million a year earlier.
Wall Street expected a loss of $0.09 a share, on revenue of $13.2 million.
Rockwell didn't immediately provide earnings guidance.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in